Cargando…

Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1

SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a γ-herpesvirus residing in over 90% of adults worldwide. Besides causing a benign glandular fever (infectious mononucleosis), EBV is also associated with a wide range of different types of cancers. This review will present these malignancies, current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knerr, Julius Maximilian, Kledal, Thomas Nitschke, Rosenkilde, Mette Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392491/ https://www.ncbi.nlm.nih.gov/pubmed/34439235 http://dx.doi.org/10.3390/cancers13164079

Ejemplares similares

Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis
por: Mavri, Maša, et al.
Publicado: (2023)

Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
por: Fares, Suzan, et al.
Publicado: (2019)

Correction: Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis
por: Mavri, Maša, et al.
Publicado: (2023)

Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality
por: Mavri, Maša, et al.
Publicado: (2022)

Viral G Protein–Coupled Receptors Encoded by β- and γ-Herpesviruses
por: Rosenkilde, Mette M., et al.
Publicado: (2022)

Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
por: Berg, Christian, et al.
Publicado: (2023)

Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021)

Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021)

Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022)

Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels?
por: Toft-Bertelsen, Trine L., et al.
Publicado: (2022)

Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells
por: Spiess, Katja, et al.
Publicado: (2017)

Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial
por: Weis, Nina, et al.
Publicado: (2023)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
por: Rozman, Marija, et al.
Publicado: (2022)

GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists
por: Holst, Jens Juul, et al.
Publicado: (2020)

Methods for Studying Endocytotic Pathways of Herpesvirus Encoded G Protein-Coupled Receptors
por: Mavri, Maša, et al.
Publicado: (2020)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

EBV‐encoded miRNAs target ATM‐mediated response in nasopharyngeal carcinoma
por: Lung, Raymond W‐M, et al.
Publicado: (2018)

Genome Sequence and QTL Analyses Using Backcross Recombinant Inbred Lines (BILs) and BILF(1) Lines Uncover Multiple Heterosis-related Loci
por: Yu, Yahui, et al.
Publicado: (2020)

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases
por: Jin, Jin, et al.
Publicado: (2023)

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2015)

Genetic variability and mutation of Epstein‒Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines
por: Wang, Yue, et al.
Publicado: (2023)

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein
por: Krishna, B. A., et al.
Publicado: (2017)

Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
por: Iwakiri, Dai, et al.
Publicado: (2009)

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2020)

Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer
por: Atri-Schuller, Aviva, et al.
Publicado: (2022)

EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1
por: Lung, Raymond Wai‐Ming, et al.
Publicado: (2020)

The EBV-encoded Latent Membrane Proteins, LMP2A and LMP2B, Limit the Actions of Interferon by Targeting Interferon Receptors for Degradation
por: Shah, Khilan M., et al.
Publicado: (2009)

Oncogenic Properties of the EBV ZEBRA Protein
por: Germini, Diego, et al.
Publicado: (2020)

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases
por: Mundo, Lucia, et al.
Publicado: (2017)

EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
por: Li, Zhi, et al.
Publicado: (2015)

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
por: Yang, Lifang, et al.
Publicado: (2010)

Modification of Cɛ mRNA Expression by EBV-Encoded Latent Membrane Protein 1
por: Hanashiro, Kazuhiko, et al.
Publicado: (2006)

Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes
por: Ahmed, Waqar, et al.
Publicado: (2018)

The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2021)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives
por: Wyżewski, Zbigniew, et al.
Publicado: (2022)

EBV-associated diseases: Current therapeutics and emerging technologies
por: Chakravorty, Srishti, et al.
Publicado: (2022)

Pathogenesis and therapeutic implications of EBV-associated epithelial cancers
por: Low, Yi Hua, et al.
Publicado: (2023)

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target
por: Emanuel, Oscar, et al.
Publicado: (2021)

Biased and G Protein-Independent Signaling of Chemokine Receptors
por: Steen, Anne, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2l1jf0fpd6oaft95je45ipj3hk